← Eichor
Condition: Antineoplastic Agents Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Antineoplastic Agents

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Phase 1 · 1 location(s) · Ascentage Pharma Group Inc. · NCT06687070Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Phase 4 · 2 location(s) · Wei Zhao · NCT03844360Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04449549Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Horm
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06621459Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110Impact of Changing the Appearance of Oral Antineoplastics on Adherence and Continuity of Treatment, Patient-reported Hea
Phase N/A · 1 location(s) · Universidad Miguel Hernandez de Elche · NCT07664683AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Phase 1/Phase 2 · 43 location(s) · AstraZeneca · NCT06106945GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07511413DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770102Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · 8 location(s) · Acerand Therapeutics (Hong Kong) Limited · NCT06801236Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanom
Phase 1 · 2 location(s) · Yana Najjar · NCT04572451A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Phase 1/Phase 2 · 4 location(s) · OncoResponse, Inc. · NCT06090266Antineoplastic Drugs in Elderly Patients
Phase N/A · 1 location(s) · Shandong University · NCT05467189A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · 17 location(s) · Biohaven Therapeutics Ltd. · NCT06384807A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate C
Phase 1/Phase 2 · 19 location(s) · GlaxoSmithKline · NCT06990880IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · 13 location(s) · Iksuda Therapeutics Ltd. · NCT05365659FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07467434A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agent
Phase 1/Phase 2 · 8 location(s) · Bristol-Myers Squibb · NCT07223047Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.
Phase 4 · 1 location(s) · Hospital JP Garrahan · NCT03500133A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06520488Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Revolution Medicines, Inc. · NCT07397338Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
NA · 1 location(s) · University of Milan · NCT06381726Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · 52 location(s) · AstraZeneca · NCT07181161A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refract
Phase 1/Phase 2 · 22 location(s) · AstraZeneca · NCT07123454A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · LaNova Medicines Limited · NCT06682780Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
Phase N/A · 2 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT06940102uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Phase N/A · 22 location(s) · UroGen Pharma Ltd. · NCT05874921Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Phase 2 · 20 location(s) · Fundación GECP · NCT07242547Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Phase 1/Phase 2 · 60 location(s) · AstraZeneca · NCT05797168
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.